Feb 24, 2006
Glaxo defends Flonase
The FDA, under fire for sluggishness in approving generic drugs, announced this week that it had OKed a generic version of the popular nasal spray Flonase. In response, the drug's maker, GlaxoSmithKline, took legal action to halt the move. Helen Palmer reports from the Health Desk at WGBH.
3 hours ago25:22
11 hours ago7:09
16 hours ago30:57
16 hours ago12:45
6 days ago28:44
4 months ago24:33